Epilepsy is a neurological disorder affecting the central nervous system. In this medical condition, the brain exhibits abnormal activity, which results in periods of unusual behavior or seizures and sometimes, loss of awareness. Temporary confusion, anxiety, uncontrollable jerking movements of the arms and legs, and others are some of the common symptoms of the disease.
Increasing prevalence of epilepsy is a major driver for the market. According to a report by the World Health Organization (2018), about 50 million people across the world are estimated to suffer from epilepsy, making it one of the most common neurological diseases. In addition, the report states that the total number of people aged 65 or more is projected to increase from 524 million in 2010 to approximately 1.5 billion by 2050.

Market Analysis and Insights: Global Epilepsy Diagnosis & Treatment Market
The global Epilepsy Diagnosis & Treatment market size is projected to reach US$ 21010 million by 2027, from US$ 7778.7 million in 2020, at a CAGR of 15.0% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Epilepsy Diagnosis & Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Epilepsy Diagnosis & Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Epilepsy Diagnosis & Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Epilepsy Diagnosis & Treatment market.

Global Epilepsy Diagnosis & Treatment Scope and Market Size
Epilepsy Diagnosis & Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Epilepsy Diagnosis & Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Diagnosis (Neurological Exam, Blood Test, Imaging)
Treatment (Medication, Surgery)

Segment by Application
Hospitals
Clinics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Johnson & Johnson
UCB Pharma
Abbott
GlaxoSmithKline
Novartis
Sanofi
Takeda
Medtronic
Natus Medical
Siemens